Loading...

US Recommends ‘Pause’ for J&J Vaccine Over Clot Reports

April 13, 2021by Zeke Miller, Associated Press

WASHINGTON (AP) — The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating clots in six women that occurred in the days after vaccination. The clots were observed along with reduced platelet counts — making the usual treatment for blood clots, the blood thinner heparin, potentially “dangerous.”
More than 6.8 million doses of the J&J vaccine have been administered in the U.S., the vast majority with no or mild side effects.
U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot, and states and other providers are expected to follow. The other two authorized vaccines, from Moderna and Pfizer, are not affected by the pause.
CDC’s Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases and the FDA has also launched an investigation into the cause of the clots and low platelet counts.
“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Anne Schuchat, Principal Deputy Director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a joint statement.
They are recommending that people who were given the J&J vaccine who are experiencing severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after receiving the shot contact their health care provider.
Officials say they also want to educate vaccine providers and health professionals about the “unique treatment” required for this type of clot.
The J&J vaccine received emergency use authorization from the FDA in late February with great fanfare, with hopes that its single-dose and relatively simple storage requirements would speed vaccinations across the country. Yet the shot only makes up a small fraction of the doses administered in the U.S. as J&J has been plagued by production delays and manufacturing errors at the Baltimore plant of a contractor.
Last week the drugmaker took over the facility to scale up production in hopes of meeting its commitment to the U.S. government of providing about 100 million doses by the end of May.
Until now concern about the unusual blood clots has centered on the vaccine from AstraZeneca, which has not yet received authorization in the U.S. Last week, European regulators said they found a possible link between the shots and a very rare type of blood clot that occurs together with low blood platelets, one that seems to occur more in younger people.
The European Medicines Agency stressed that the benefits of receiving the vaccine outweigh the risks for most people. But several countries have imposed limits on who can receive the vaccine; Britain recommended that people under 30 be offered alternatives.
But the J&J and AstraZeneca vaccines are made with the same technology. Leading COVID-19 vaccines train the body to recognize the spike protein that coats the outer surface of the coronavirus. But the J&J and AstraZeneca vaccines use a cold virus, called an adenovirus, to carry the spike gene into the body. J&J uses a human adenovirus to create its vaccine while AstraZeneca uses a chimpanzee version.
The announcement hit U.S. stock markets immediately, with Dow futures falling almost 200 points just over two hours before the opening bell. Shares of Johnson & Johnson dropped almost 3%

Health

November 29, 2021
by Dan McCue
Biden Tells Americans New COVID Variant ‘Not Cause for Panic’

WASHINGTON — President Joe Biden addressed the nation Monday, calling the new omicron variant of the coronavirus a cause for... Read More

WASHINGTON — President Joe Biden addressed the nation Monday, calling the new omicron variant of the coronavirus a cause for concern “but not a cause for panic.” Speaking in the Roosevelt Room of the White House, as Dr. Anthony Fauci, director of the National Institute of... Read More

Biden Pushes Shots, Not More Restrictions as Variant Spreads

WASHINGTON (AP) — President Joe Biden will urge Americans to get vaccinated and to receive a booster shot as he... Read More

WASHINGTON (AP) — President Joe Biden will urge Americans to get vaccinated and to receive a booster shot as he seeks to quell concerns Monday over the new COVID-19 variant omicron, but won't immediately push for more restrictions to stop its spread, his chief medical adviser said.... Read More

Supreme Court Set to Take Up All-or-Nothing Abortion Fight

WASHINGTON (AP) — Both sides are telling the Supreme Court there's no middle ground in Wednesday's showdown over abortion. The justices can... Read More

WASHINGTON (AP) — Both sides are telling the Supreme Court there's no middle ground in Wednesday's showdown over abortion. The justices can either reaffirm the constitutional right to an abortion or wipe it away altogether. Roe v. Wade, the landmark 1973 ruling that declared a nationwide right to abortion, is... Read More

Fauci Fires Back at Cruz Over COVID Claims About Chinese Lab

WASHINGTON (AP) — Dr. Anthony Fauci, the government’s top infectious diseases expert, blasted Sen. Ted Cruz for suggesting that Fauci... Read More

WASHINGTON (AP) — Dr. Anthony Fauci, the government’s top infectious diseases expert, blasted Sen. Ted Cruz for suggesting that Fauci be investigated for statements he made about COVID-19 and said the criticism by the Texas Republican was an attack on science. “I should be prosecuted? What happened on... Read More

November 26, 2021
by Dan McCue
US Restricts Travel From 8 Countries in Response to Omicron Variant

WASHINGTON - The Biden Administration on Friday imposed air travel restrictions on eight African nations in response to a new... Read More

WASHINGTON - The Biden Administration on Friday imposed air travel restrictions on eight African nations in response to a new COVID strain first detected in South Africa. The new travel restrictions, which go into effect Monday, apply to citizens of South Africa, Botswana, Zimbabwe, Namibia, Lesotho,... Read More

World Takes Action as New Variant Emerges in Southern Africa

BRUSSELS (AP) — A slew of nations moved to stop air travel from southern Africa on Friday, and stocks plunged... Read More

BRUSSELS (AP) — A slew of nations moved to stop air travel from southern Africa on Friday, and stocks plunged in Asia and Europe in reaction to news of a new, potentially more transmissible COVID-19 variant. "The last thing we need is to bring in a... Read More

News From The Well
Exit mobile version